Leticia Campos Clemente

6PUBLICATIONS
54CO-AUTHORS
Diagnostic radiographyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 21, 2026
Enhancing Pathology Knowledge for Biomedical Scientists: Pilot Cohort Study of a Comprehensive Self-Paced Tutorial for Bridging Fundamental Concepts With Translational Applications.

|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

Melinda Soeung, Xinmiao Yan, Ciro Zanca

|Nov 13, 2025
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Potential Marker of HPV-Independent Disease.

Jamaal C Jackson, Andrew C Johns, Leticia Campos Clemente

|Oct 03, 2022
Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates.

Shailbala Singh, Leticia C Clemente, Edwin R Parra

|Apr 12, 2022
Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy.

Carolina Mantilla-Rojas, Fred C Velasquez, Janelle E Morton

|May 10, 2021
Extranodal NK/T-cell lymphoma, nasal type with extensive cardiopulmonary involvement.

Mario L Marques-Piubelli, Gabriel Teixeira Montezuma Sales, Letícia Campos Clemente

Pageof 1

Frequent Collaborators

2 joint publications

Edwin R Parra

2 joint publications

Niki Marie Zacharias

1 joint publications

Carlos Torres-Cabala

1 joint publications

Eva M Sevick-Muraca